BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, May 7, 2026
Home » Topics » Financings, Medical technology

Financings, Medical technology
Financings, Medical technology RSS Feed RSS

Financings for Feb. 24, 2025

Feb. 24, 2025
Med-tech firms raising money in public or private financings, including: Boston Scientific, Firefly Neuroscience Inc., Organox, Pavmed, Sonar, Veris Health.
Read More

Financings for Feb. 21, 2025

Feb. 21, 2025
Med-tech firms raising money in public or private financings, including: Allurion, Cagent Vascular, Intelligent Bio, Precision Optics.
Read More

Financings for Feb. 20, 2025

Feb. 20, 2025
Med-tech firms raising money in public or private financings, including: Anbio Biotechnology Ltd., Approxima Srl, Atrandi Biosciences, Level Zero Health., Valencia Technologies, Vitalconnect Inc.
Read More
Human sperm image

Posterity looks to future with $13M round for male fertility care

Feb. 19, 2025
By Annette Boyle
Fifty percent of infertility cases arise from issues with the male partner, but standard protocols often delay the first assessment of males for at least two years. Posterity Health Inc. aims to usher in a new generation of fertility care starting with its just-closed $13 million series A financing round.
Read More
Tinted Euro symbol

Cardiovascular, robotics and AI attract European VCs

Feb. 19, 2025
By Shani Alexander
Med-tech companies focusing on cardiovascular diseases or neurological conditions, women’s health or robotic surgery, will find European investors willing to deploy capital into their stories. European venture capital firms are excited about the continuing innovation and opportunities in the sector.
Read More

Financings for Feb. 19, 2025

Feb. 19, 2025
Med-tech firms raising money in public or private financings, including: Allurion Technologies, Applyo Jena, Logicmark, Neuropace, Tempus AI.
Read More
Dongkook hq

Dongkook Life Science secures ₩18B IPO

Feb. 18, 2025
By Marian (YoonJee) Chu
Dongkook Life Science Co. Ltd. (DKLS) priced a ₩18 billion (US$12.5 million) IPO on the Korea Exchange as South Korea’s first med-tech listing of the year.
Read More
Germitec Chronos

Germitec raises $30M to bring UV-C disinfection tech to US

Feb. 18, 2025
By Shani Alexander
Germitec SA raised $30 million in a series B financing round to bring Chronos, its chemical-free, ultraviolet-C (UV-C)-based disinfection system for ultrasound probes, to the U.S. market.
Read More

Financings for Feb. 18, 2025

Feb. 18, 2025
Med-tech firms raising money in public or private financings, including: Endovascular Engineering, Quokka Care, Spectral AI, Subsense.
Read More
Australian money

Harrison.ai raises AU$179M in series C round to fuel global expansion

Feb. 14, 2025
By Tamra Sami
Harrison.ai raised AU$179 million (US$112 million) in a series C round to expand its radiology and pathology solutions across the U.S., Europe, the Middle East, Africa and Asia Pacific.
Read More
Previous 1 2 … 34 35 36 37 38 39 40 41 42 … 257 258 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 6, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • Regulatory actions for May 5, 2026

    BioWorld
    Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing